期刊文献+

他汀类药物对慢性心力衰竭治疗作用的新认识 被引量:1

Advances in Statins in Treatment for Chronic Heart Failure
下载PDF
导出
摘要 他汀类药物具有肯定的降血脂作用,已作为冠状动脉粥样硬化性心脏病的二级预防用药。大量研究显示,他汀类药物除降脂作用外,还有多效的非调脂作用如抗炎作用、改善内皮功能、改善心室重塑、恢复心脏自主神经功能、抗氧化作用。近年来很多研究表明,他汀类药物的多效性对慢性心力衰竭的治疗有益,可延缓慢性心力衰竭进展,改善心功能,降低慢性心力衰竭病死率、致残率。但同时也有一些潜在的不利影响,他汀类药物能否常规用于慢性心力衰竭的治疗还有待循证医学证实。 Statins plays a role in reducing blood-fat cholesterol,acting as a second-level prevention drug for coronary artery disease.Many studies have shown that statins has many other contributions such as anti-inflammation,anti-ventricular remodeling,anti-arrhythmia,anti-oxidat besides the effect on blood fat decrease.Recent studies showed that this drug can be used to treat chronic heart failure,which can prevent progress of chronic heart failure,improve hear function and decrease case fatality and mutilation rate of chronic heart failure.At the same time it maybe have some bad effects.We need more clinical evidences on statins treating for chronic heart failure.
出处 《医学综述》 2009年第21期3288-3290,共3页 Medical Recapitulate
关键词 他汀类药物 慢性心力衰竭 作用机制 Statins Chronic heart failure Mechanism of action
  • 相关文献

参考文献3

二级参考文献28

  • 1Bauersachs J, Galuppo P, Fraccarollo D, et al. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction [J]. Circulation, 2001
  • 2Hayashidani S, Tsutsui H, Shiomi T, et al. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction [J]. Circulation, 2002, 105:868
  • 3Patel R, Nagueh SF, Tsybouleva N, et al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy [J]. Circulation, 2001,104:317
  • 4Laufs U, La Fata V, Plutzky J, et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors [J]. Circulation, 1998, 97:1129.
  • 5Oi S, Haneda T, Osaki J, et al. Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells [J]. Eur J Pharmacol, 1999, 376:139
  • 6Luo JD, Zhang WW, Zhang GP, et al. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis [J]. Clin Exp Pharmacol Physiol, 1999, 26:903
  • 7Dechend R, Fiebeler A, Park JK, et al. Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor [J]. Circulation, 2001,104:576
  • 8Luan Z, Chase AJ, Newby AC. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages[J]. Arterioscler Thromb Vasc Biol, 2003, 23:769
  • 9Ikeda U, Shimpo M, Ohki R, et al. Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells [J]. Hypertension, 2000, 36:325
  • 10Bellosta S, Via D, Canavesi M, et al. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages [J]. Arterioscler Thromb Vasc Biol, 1998, 18:1671

共引文献63

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部